Detalles de la búsqueda
1.
Management and long-term clinical outcomes of patients with stage IVA cervical cancer with bladder involvement.
Gynecol Oncol
; 180: 24-34, 2024 Jan.
Artículo
en Inglés
| MEDLINE | ID: mdl-38041900
2.
Survival disparities in non-Hispanic Black and White cervical cancer patients vary by histology and are largely explained by modifiable factors.
Gynecol Oncol
; 184: 224-235, 2024 Feb 09.
Artículo
en Inglés
| MEDLINE | ID: mdl-38340648
3.
Disease progression, survival, and molecular disparities in Black and White patients with endometrioid endometrial carcinoma in real-world registries and GOG/NRG oncology randomized phase III clinical trials.
Gynecol Oncol
; 183: 103-114, 2024 Apr.
Artículo
en Inglés
| MEDLINE | ID: mdl-38593674
4.
Quality-adjusted survival in women with gynecologic malignancies receiving IMRT after surgery: A Ppatient Rreported Ooutcome study of NRG oncology's RTOG 1203.
Gynecol Oncol
; 175: 176-181, 2023 08.
Artículo
en Inglés
| MEDLINE | ID: mdl-37393743
5.
Identifying the optimal deep learning architecture and parameters for automatic beam aperture definition in 3D radiotherapy.
J Appl Clin Med Phys
; 24(12): e14131, 2023 Dec.
Artículo
en Inglés
| MEDLINE | ID: mdl-37670488
6.
Metagenomes of rectal swabs in larger, advanced stage cervical cancers have enhanced mucus degrading functionalities and distinct taxonomic structure.
BMC Cancer
; 22(1): 945, 2022 Sep 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-36050658
7.
Long-term survival following definitive radiation therapy for recurrence or oligometastases in gynecological malignancies: A landmark analysis.
Gynecol Oncol
; 164(3): 550-557, 2022 03.
Artículo
en Inglés
| MEDLINE | ID: mdl-34974906
8.
Update on MRI in Evaluation and Treatment of Endometrial Cancer.
Radiographics
; 42(7): 2112-2130, 2022.
Artículo
en Inglés
| MEDLINE | ID: mdl-36018785
9.
Impact of treatment modality on pelvic floor dysfunction among uterine cancer survivors.
Int J Gynecol Cancer
; 2022 Jun 09.
Artículo
en Inglés
| MEDLINE | ID: mdl-35680139
10.
Uterine carcinosarcomas: From pathology to practice.
Gynecol Oncol
; 162(1): 235-241, 2021 07.
Artículo
en Inglés
| MEDLINE | ID: mdl-34030871
11.
Early and Midtreatment Mortality in Palliative Radiotherapy: Emphasizing Patient Selection in High-Quality End-of-Life Care.
J Natl Compr Canc Netw
; 19(7): 805-813, 2021 04 20.
Artículo
en Inglés
| MEDLINE | ID: mdl-33878727
12.
A phase III study of transdermal granisetron versus oral ondansetron for women with gynecologic cancers receiving pelvic chemoradiation.
Support Care Cancer
; 29(1): 213-222, 2021 Jan.
Artículo
en Inglés
| MEDLINE | ID: mdl-32338316
13.
Pelvic fractures and changes in bone mineral density after radiotherapy for cervical, endometrial, and vaginal cancer: A prospective study of 239 women.
Cancer
; 126(11): 2607-2613, 2020 06 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-32125711
14.
Radiation therapy for gynecologic malignancies during the COVID-19 pandemic: International expert consensus recommendations.
Gynecol Oncol
; 158(2): 244-253, 2020 08.
Artículo
en Inglés
| MEDLINE | ID: mdl-32563593
15.
Tumor microbial diversity and compositional differences among women in Botswana with high-grade cervical dysplasia and cervical cancer.
Int J Gynecol Cancer
; 30(8): 1151-1156, 2020 08.
Artículo
en Inglés
| MEDLINE | ID: mdl-32675252
16.
Gut microbial diversity and genus-level differences identified in cervical cancer patients versus healthy controls.
Gynecol Oncol
; 155(2): 237-244, 2019 11.
Artículo
en Inglés
| MEDLINE | ID: mdl-31500892
17.
Prognostic factors impacting survival in early stage uterine carcinosarcoma.
Gynecol Oncol
; 152(1): 31-37, 2019 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-30414738
18.
Brachytherapy: A critical component of primary radiation therapy for cervical cancer: From the Society of Gynecologic Oncology (SGO) and the American Brachytherapy Society (ABS).
Gynecol Oncol
; 152(3): 540-547, 2019 03.
Artículo
en Inglés
| MEDLINE | ID: mdl-30665615
19.
National trends, outcomes, and costs of radiation therapy in the management of low- and high-intermediate risk endometrial cancer.
Gynecol Oncol
; 152(3): 439-444, 2019 03.
Artículo
en Inglés
| MEDLINE | ID: mdl-30876486
20.
Adjuvant combined-modality therapy for stage IIIC endometrioid and non-endometrioid endometrial cancer.
Gynecol Oncol
; 154(1): 22-28, 2019 07.
Artículo
en Inglés
| MEDLINE | ID: mdl-31109659